M. tuberculosis: immunology and vaccination

Rook G.A.W., Seah G., Ustianowski A.

Source: Eur Respir J 2001; 17: 537-557
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rook G.A.W., Seah G., Ustianowski A.. M. tuberculosis: immunology and vaccination. Eur Respir J 2001; 17: 537-557

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012


COVID-19 vaccines: immunology, regulation and clinical management
Source: Eur Respir Monogr 2021; 94: 244-260
Year: 2021


How do antigen presenting cells see pathogens and cells?
Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases
Year: 2006


Immunotherapy (as an adjuvant therapeutic tool) of tuberculosis - does it have a future?
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

TB in children
Source: Eur Respir Mon 2012; 58: 206-218
Year: 2012


The role of virus infections in asthma: immune responses and future possibilities
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


Aetiopathogenesis, immunology and microbiology of tuberculosis
Source: Eur Respir Monogr 2018; 82: 62-82
Year: 2018


Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012


The future of targeted therapies for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005

Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
Source: Eur Respir J 2006; 28: 31-34
Year: 2006



Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010



Delivery of siRNA to the lungs and airways
Source: Annual Congress 2005 - Selective gene knockout - the use of small interference RNA
Year: 2005

Lung dendritic cells and host immunity to infection
Source: Eur Respir J 2001; 18: 692-704
Year: 2001



New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Identification and characterisation of isolated human lung dendritic cells (DCs)
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006


Omics and single molecule detection: the future of TB diagnostics
Source: Eur Respir Mon 2012; 58: 144-153
Year: 2012


Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009



Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016